Scarica l'app Stockscreener
14.39
1.34%
0.19
Dopo l'orario di chiusura:
14.30
-0.09
-0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$14.20
Aprire:
$14.2
Volume 24 ore:
422.30K
Relative Volume:
0.54
Capitalizzazione di mercato:
$428.08M
Reddito:
$30.43M
Utile/perdita netta:
$-18.15M
Rapporto P/E:
-20.86
EPS:
-0.69
Flusso di cassa netto:
$-9.08M
1 W Prestazione:
+3.53%
1M Prestazione:
+2.64%
6M Prestazione:
+28.14%
1 anno Prestazione:
-15.35%
Intervallo 1D:
$13.90
$14.44
Intervallo di 1 settimana:
$13.51
$16.50
Portata 52W:
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Confronta CLPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.39 | 422.43M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
CLPT Gets EU MDR Certification for ClearPoint Navigation Software - Finviz
ClearPoint Neuro: From Validation To Scale (NASDAQ:CLPT) - Seeking Alpha
Market Review: Can NextPlat Corp Equity Warrant outperform under higher oil pricesRisk Management & Growth Focused Investment Plans - baoquankhu1.vn
Quarterly Earnings: Will Georgia Power Company Preferred Security be affected by tariffsBreakout Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software - Sahm
ClearPoint Neuro receives EU MDR certification for navigation software By Investing.com - Investing.com Australia
ClearPoint Neuro stock rises after receiving EU MDR certification By Investing.com - Investing.com South Africa
ClearPoint Neuro stock rises after receiving EU MDR certification - Investing.com
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - BioSpace
ClearPoint Neuro receives EU MDR certification for navigation software - Investing.com
New brain surgery software opens CT-guided option for hospitals without MRI - Stock Titan
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 107% Potential Upside with Analyst Confidence - directorstalkinterviews.com
While institutions own 40% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 52% ownership - Yahoo Finance
Published on: 2026-01-16 07:23:49 - baoquankhu1.vn
Precision Trading with Clearpoint Neuro, Inc. (CLPT) Risk Zones - Stock Traders Daily
ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $322,400.00 in Stock - MarketBeat
Earnings Risk: Will ClearPoint Neuro Inc stock deliver better than expected guidance2025 Valuation Update & Long-Term Growth Portfolio Plans - Bộ Nội Vụ
ClearPoint Neuro reports 20% sales growth in Q4 2025 By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Preliminary Revenue Growt - GuruFocus
CLPT Forecasts Strong Revenue Growth by 2026 - GuruFocus
ClearPoint Neuro sees Q4 revenue $10.4M, up 20% y/y - TipRanks
ClearPoint Neuro (CLPT) Reports Strong Q4 2025 Revenue Growth - GuruFocus
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue - morningsun.net
ClearPoint Neuro prelim Q4 revenue rises - TradingView
ClearPoint Neuro reports 20% sales growth in Q4 2025 - Investing.com
How ClearPoint Neuro Inc. stock benefits from tech adoption2025 Top Decliners & High Return Trade Opportunity Guides - ulpravda.ru
Is ClearPoint Neuro Inc. stock attractive after correctionJuly 2025 Trade Ideas & Weekly High Conviction Ideas - Улправда
ClearPoint Neuro restructures IRRAS subsidiary under debt agreement - MSN
Will ClearPoint Neuro Inc. stock attract ESG investors2025 Analyst Calls & Fast Gaining Stock Reports - ulpravda.ru
ClearPoint Neuro enters consent agreement related to IRRAS AB reorganization - Investing.com Australia
ClearPoint Neuro Restructures IRRAS Subsidiary Under Debt Agreement - TipRanks
ClearPoint Neuro Signs Consent to Note Purchase Agreement With Oberland Capital - TradingView — Track All Markets
Technical Reactions to CLPT Trends in Macro Strategies - Stock Traders Daily
ClearPoint Neuro enters consent agreement related to IRRAS AB reorganization By Investing.com - Investing.com Nigeria
Published on: 2025-12-27 12:00:42 - bollywoodhelpline.com
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a Potential 100% Upside in the Healthcare Sector - DirectorsTalk Interviews
What Creates a Long-Term Growth Opportunity for ClearPoint Neuro (CLPT)? - Insider Monkey
(CLPT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What analysts say about ClearPoint Neuro Inc stockEquity Performance Review & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet? - 富途牛牛
Is ClearPoint Neuro Stock Built to Withstand a Pullback? - Trefis
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):